Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

BRE over-expression promotes growth of hepatocellular carcinoma.

Chui YL, Ching AK, Chen S, Yip FP, Rowlands DK, James AE, Lee KK, Chan JY.

Biochem Biophys Res Commun. 2010 Jan 15;391(3):1522-5. doi: 10.1016/j.bbrc.2009.12.111. Epub 2009 Dec 24.

PMID:
20035718
2.

BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinoma.

Chan BC, Ching AK, To KF, Leung JC, Chen S, Li Q, Lai PB, Tang NL, Shaw PC, Chan JY, James AE, Lai KN, Lim PL, Lee KK, Chui YL.

Oncogene. 2008 Feb 21;27(9):1208-17. Epub 2007 Aug 20.

PMID:
17704801
3.

BRE enhances in vivo growth of tumor cells.

Chan BC, Li Q, Chow SK, Ching AK, Liew CT, Lim PL, Lee KK, Chan JY, Chui YL.

Biochem Biophys Res Commun. 2005 Jan 14;326(2):268-73.

PMID:
15582573
4.

Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.

Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST.

Clin Cancer Res. 2004 Nov 15;10(22):7629-36.

5.

Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.

de la Monte SM, Tamaki S, Cantarini MC, Ince N, Wiedmann M, Carter JJ, Lahousse SA, Califano S, Maeda T, Ueno T, D'Errico A, Trevisani F, Wands JR.

J Hepatol. 2006 May;44(5):971-83. Epub 2006 Mar 10.

PMID:
16564107
6.

RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.

Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.

J Gastroenterol Hepatol. 2008 Sep;23(9):1448-58. Epub 2007 Aug 6.

PMID:
17683489
7.

Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis.

Zimmers TA, Jin X, Gutierrez JC, Acosta C, McKillop IH, Pierce RH, Koniaris LG.

J Cancer Res Clin Oncol. 2008 Jul;134(7):753-9. doi: 10.1007/s00432-007-0336-4. Epub 2008 Jan 22.

PMID:
18210153
8.

Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.

Yam JW, Ko FC, Chan CY, Yau TO, Tung EK, Leung TH, Jin DY, Ng IO.

Hepatology. 2006 Oct;44(4):881-90.

PMID:
17006924
9.

Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.

Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK.

J Pathol. 2009 Aug;218(4):520-9. doi: 10.1002/path.2563.

PMID:
19431154
10.

Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.

Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK, Lee MO.

Oncogene. 2008 May 29;27(24):3405-13. doi: 10.1038/sj.onc.1211000. Epub 2008 Feb 11.

PMID:
18264140
11.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109. Epub 2007 Jul 26.

PMID:
17698398
12.
13.

Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.

Luan F, Liu H, Gao L, Liu J, Sun Z, Ju Y, Hou N, Guo C, Liang X, Zhang L, Sun W, Ma C.

Gut. 2009 Nov;58(11):1528-37. doi: 10.1136/gut.2008.174029. Epub 2009 Aug 2.

PMID:
19651630
14.

LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis.

Huang X, Ji G, Wu Y, Wan B, Yu L.

J Cancer Res Clin Oncol. 2008 Jun;134(6):705-14. Epub 2007 Dec 14.

PMID:
18084776
15.

Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.

Hellerbrand C, Mühlbauer M, Wallner S, Schuierer M, Behrmann I, Bataille F, Weiss T, Schölmerich J, Bosserhoff AK.

Carcinogenesis. 2006 Jan;27(1):64-72. Epub 2005 Aug 4.

16.
17.

Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.

Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.

Am J Pathol. 1996 Aug;149(2):407-28.

18.

A novel liver-specific zona pellucida domain containing protein that is expressed rarely in hepatocellular carcinoma.

Xu ZG, Du JJ, Zhang X, Cheng ZH, Ma ZZ, Xiao HS, Yu L, Wang ZQ, Li YY, Huo KK, Han ZG.

Hepatology. 2003 Sep;38(3):735-44.

PMID:
12939600
19.
20.
Items per page

Supplemental Content

Write to the Help Desk